Is Vijaya Diagnostic Centre a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Vijaya Diagnostic Centre Ltd is a good quality company .

Is Vijaya Diagnostic Centre undervalued or overvalued?

The key valuation ratios of Vijaya Diagnostic Centre Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone .

What is Vijaya Diagnostic Centre share price return in the past 10 years?

Data is not available for this company

Is Vijaya Diagnostic Centre a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Vijaya Diagnostic Centre Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

What is the P/E ratio of Vijaya Diagnostic Centre?

The latest standalone P/E ratio of Vijaya Diagnostic Centre as of 09-Apr-2025 is 79.14.

What is the P/B ratio of Vijaya Diagnostic Centre?

The latest standalone P/B ratio of Vijaya Diagnostic Centre as of 09-Apr-2025 is 13.98.

What is the 52-week high and low of Vijaya Diagnostic Centre?

The 52-week high of Vijaya Diagnostic Centre is Rs. 1276.75 and the 52-week low is Rs. 649.00.

Vijaya Diagnostic Centre Ltd - Stock Valuation and Financial Performance

Name: Vijaya Diagnostic Centre
Brand: Vijaya Diagnostic Centre

BSE: 543350 | NSE: VIJAYA | Hospital & Healthcare Services | Small Cap

Place order

Vijaya Diagnostic Share Price

₹986.55 -34.35 -3.36%
as on 09-Apr'25 10:14

DeciZen - make an informed investing decision on Vijaya Diagnostic

Based on:

Data

Overall Rating ⓘ
Login to view analysis.

1. Quality

2. Valuation

3. Price Trend

Vijaya Diagnostic Centre stock performance -

₹986.55 315.0047.00% past year

PE Chart Key Ratios

Price Chart, Live Stock Chart, Technical Chart of

P/E Ratio (CD):

73.85

Market Cap:

10,478.1 Cr.

52-wk low:

649

52-wk high:

1,276.8

Related Stocks

Is Vijaya Diagnostic Centre Ltd an attractive stock to invest in?

10 Year X-Ray of Vijaya Diagnostic: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	0%	0%	0%	0%	31.6%	35.5%	38%	39.4%	26.5%	30.4%	-
Value Creation Index ⓘ	NA	NA	NA	NA	1.3	1.6	1.8	1.8	0.9	1.3	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	0	0	293	339	377	462	459	548	663
Sales YoY Gr.	-	NA	NA	NA	NA	15.8%	11.2%	22.7%	-0.7%	19.3%	-
Adj EPS ⓘ	0	0	0	0	4.5	6	8.3	10.7	8.3	11.8	13.8
YoY Gr.	-	NA	NA	NA	NA	34.2%	37.6%	29.5%	-22.6%	42.7%	-
BVPS (₹) ⓘ	0	0	0	0	20.1	26.9	35.1	45.7	53.2	64.1	74.1
Adj Net Profit ⓘ	0	0	0	0	45.6	61.3	84.4	109	84.6	121	142
Cash Flow from Ops. ⓘ	0	0	0	0	90.5	106	130	158	165	183	-
Debt/CF from Ops. ⓘ	0	0	0	0	0.5	0.3	0	0	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	13.4%	13.3%	19.3%
Adj EPS ⓘ	NA	21.4%	12.7%	42.7%
BVPSⓘ	NA	26.1%	22.2%	20.5%
Share Price	-	-	29.3%	47%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	22	25.4	26.6	26.4	16.7	20.2	20
Op. Profit Mgn % ⓘ	37	39.1	44.1	44.1	39.6	40.3	40.3
Net Profit Mgn % ⓘ	15.7	18.1	22.6	23.8	18.5	22.3	21.4
Debt to Equity ⓘ	0.2	0.1	0	0	0	0	-
Working Cap Days ⓘ	0	26	30	35	36	28	64
Cash Conv. Cycle ⓘ	0	-32	-31	-25	-27	-30	40

Recent Performance Summary

Latest Financials - Vijaya Diagnostic Centre Ltd.

	Standalone	Consolidated
TTM EPS (₹)	12.9	13.8
TTM Sales (₹ Cr.)	608	663
BVPS (₹.) ⓘ	73	74.1
Reserves (₹ Cr.) ⓘ	739	750
P/BV ⓘ	13.98	13.78
PE ⓘ	79.14	73.85

From the Market
52 Week Low / High (₹)	649.00 / 1276.75
All Time Low / High (₹)	292.00 / 1276.75
Market Cap (₹ Cr.)	10,478
Equity (₹ Cr.)	10.3
Face Value (₹)	1
Industry PE ⓘ	41.2

Quarterly Results

Standalone Basis

Consolidated Basis

	Mar'24	YoY Gr. Rt. %	Jun'24	YoY Gr. Rt. %	Sep'24	YoY Gr. Rt. %	Dec'24	YoY Gr. Rt. %
Sales (₹ Cr.)ⓘ	4	-5	3.8	-46	3.9	-53.4	4.8	-15.6
Adj EPS (₹) ⓘ	-0.5	N/A	-0	N/A	-0.5	N/A	-0	N/A
Op. Profit Mgn % ⓘ	-98.24	12976 bps	3.66	564 bps	-19.51	-1182 bps	-2.63	-332 bps
Net Profit Mgn % ⓘ	-285.22	57224 bps	-13.87	-524 bps	-30.85	-2220 bps	-12.50	-48 bps

Management X-Ray of Vijaya Diagnostic:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Vijaya Diagnostic

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

No data found!

Key Ratios of Vijaya Diagnostic

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Price Chart, Live Stock Chart, Technical Chart of

Sales (Cr.)

Price Chart, Live Stock Chart, Technical Chart of

ROE (%)

Price Chart, Live Stock Chart, Technical Chart of

ROCE (%)

Price Chart, Live Stock Chart, Technical Chart of

Peer Comparison

Company Name	CMP(₹)	Change ₹(%)	Market Cap	Net Sales (₹ Cr.)	Latest EPS (₹)	Net Profit Margin %	Latest P/E	Latest P/BV
Narayana Hrudayalay	1,691.1	6.7 (0.4%)	Small Cap	5,018	38.4	15.7	43.9	10.1
Aster DM Healthcare	492.1	11 (2.3%)	Small Cap	3,699	105.6	5.5	4.6	6.9
Dr. Lal Pathlabs	2,668.1	131.7 (5.2%)	Small Cap	1,967	55.3	19.5	45.9	9.7
Indraprastha Medical	385.7	-8.1 (-2.1%)	Small Cap	1,245	16.5	10	23.9	6.5
RainbowChildrenS Med	1,488.5	8 (0.5%)	Small Cap	1,237	23	17.4	64.4	10.5
Krishna Inst.Medi	577	-6.9 (-1.2%)	Small Cap	1,222	6.4	19.3	90.7	11.3
Kovai Medical Center	5,380.7	-157.5 (-2.8%)	Small Cap	1,220	188.7	14.8	29.4	5.9
Metropolis Health.	1,533.9	-6.8 (-0.4%)	Small Cap	1,208	29.7	11	51.9	6.5
HealthcareGlobal	518.3	-7.4 (-1.4%)	Small Cap	1,099	-0.8	3	-	6.2
Jupiter Life Line	1,465.5	-0.5 (-0%)	Small Cap	911	28	16.7	52.4	7

Shows rows:

Prev 1 2 3 4 5 Next

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	293	339	377	462	459	548
Operating Expenses ⓘ	184	206	211	259	277	330
Manufacturing Costs	22	25	33	36	44	52
Material Costs	40	44	57	71	59	65
Employee Cost	54	62	57	71	78	90
Other Costs ⓘ	68	75	63	80	96	122
Operating Profit ⓘ	108	133	166	204	182	218
Operating Profit Margin (%)	37.0%	39.1%	44.1%	44.1%	39.6%	39.7%
Other Income ⓘ	10	15	12	13	14	24
Interest ⓘ	14	15	15	16	21	24
Depreciation ⓘ	40	49	50	53	62	57
Exceptional Items ⓘ	0	0	0	0	0	-2
Profit Before Tax ⓘ	65	83	112	147	114	159
Tax ⓘ	19	21	27	37	28	39
Profit After Tax	46	63	85	111	85	120
PAT Margin (%)	15.8%	18.4%	22.6%	23.9%	18.6%	21.8%
Adjusted EPS (₹)	4.5	6.1	8.3	10.8	8.3	11.6
Dividend Payout Ratio (%)	0%	0%	0%	9%	12%	9%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	207	275	358	466	543	656
Share Capital ⓘ	7	5	5	10	10	10
Reserves ⓘ	200	270	354	456	533	646
Minority Interest	-0	-0	0	1	2	3
Debt	33	23	4	1	0	0
Long Term Debt	32	22	3	0	0	0
Short Term Debt	2	1	1	1	0	0
Trade Payables	22	22	22	22	28	33
Others Liabilities ⓘ	143	161	150	215	273	288
Total Liabilities ⓘ	405	481	535	705	845	980
Fixed Assets
Gross Block	349	392	437	589	800	1,069
Accumulated Depreciation	89	121	169	219	276	327
Net Fixed Assetsⓘ	259	272	268	370	524	742
CWIP ⓘ	3	10	9	34	28	9
Investmentsⓘ	69	55	28	54	139	109
Inventories	2	3	3	4	2	5
Trade Receivables	9	8	7	10	9	16
Cash Equivalents	53	118	194	192	116	73
Others Assetsⓘ	10	16	27	39	27	25
Total Assets ⓘ	405	481	535	705	845	980

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	91	106	130	158	165	183
PBT ⓘ	65	83	112	147	114	159
Adjustment ⓘ	43	49	53	57	68	60
Changes in Working Capital ⓘ	1	-3	-5	-7	9	-1
Tax Paid ⓘ	-19	-23	-31	-40	-26	-34
Cash Flow From Investing Activity ⓘ	-90	-31	-130	-123	-110	-142
Capex	-59	-37	-31	-121	-125	-85
Net Investments	-31	1	-103	-13	9	82
Others ⓘ	1	6	5	11	6	-140
Cash Flow From Financing Activityⓘ	-7	-30	-49	-31	-42	-45
Net Proceeds from Shares ⓘ	0	0	0	0	1	3
Net Proceeds from Borrowing ⓘ	7	-9	-28	-3	0	0
Interest Paid ⓘ	-3	-3	-1	-2	0	0
Dividend Paid ⓘ	0	0	0	0	-10	-10
Others ⓘ	-12	-17	-19	-25	-33	-37
Net Cash Flow ⓘ	-6	46	-49	4	13	-4

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	22.58	26.07	26.91	26.85	16.89	19.96
ROCE (%)	31.56	35.47	37.97	39.37	26.53	30.4
Asset Turnover Ratio	0.72	0.76	0.74	0.75	0.59	0.6
PAT to CFO Conversion(x)	1.98	1.68	1.53	1.42	1.94	1.53
Working Capital Days
Receivable Days	11	9	7	7	8	9
Inventory Days	3	3	3	3	3	2
Payable Days	196	181	140	112	153	169

Vijaya Diagnostic Centre Ltd Stock News

View All News

Vijaya Diagnostic Centre Ltd FAQs

What is the share price of Vijaya Diagnostic?

Company share prices are keep on changing according to the market conditions. The closing price of Vijaya Diagnostic on 09-Apr-2025 10:14 is ₹986.5.

What is the market cap of Vijaya Diagnostic?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 09-Apr-2025 10:14 the market cap of Vijaya Diagnostic stood at ₹10,478.1.

What is the P/E ratio of Vijaya Diagnostic?

The latest P/E ratio of Vijaya Diagnostic as of 09-Apr-2025 10:14 is 79.14.

What is the P/B ratio of Vijaya Diagnostic?

The latest P/B ratio of Vijaya Diagnostic as of 09-Apr-2025 10:14 is 13.98.

What is the 52-week high and low of Vijaya Diagnostic?

The 52-week high of Vijaya Diagnostic is ₹1,276.8 and the 52-week low is ₹649.0.

What is the TTM revenue of Vijaya Diagnostic?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vijaya Diagnostic is ₹608.3 ( Cr.) .

About Vijaya Diagnostic Centre Ltd

The company is the largest integrated diagnostic chain in southern India, by operating revenue, and also one of the fastest-growing diagnostic chain by revenue for fiscal year 2020. It offer a one-stop solution for pathology and radiology testing services to its customers through its extensive operational network, which consists of 81 diagnostic centres and 11 reference laboratories across 13 cities and towns in the states of Telangana and Andhra Pradesh and in the National Capital Region and Kolkata as on June 30, 2021.

The company offers a comprehensive range of approximately 740 routine and 870 specialized pathology tests and approximately 220 basic and 320 advanced radiology tests that cover a range of specialties and disciplines, as of June 30, 2021. Its test menu includes pathology tests ranging from basic biochemistry and clinical pathology to cytogenetics and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-rays and ultrasounds to advanced radiology tests including computerised tomography (CT) scans, magnetic resonance imaging (MRI) scans, single photon emission computed tomography (SPECT) and advanced positron emission tomography CT (PET CT).

It also offer a broad spectrum of health and wellness packages to its customers as per their requirements. The company focus on a customer centric approach to enhance the overall quality of its services for optimal customer satisfaction. For convenience of its customers, it provide value-added services such as home collection of specimens, house calls and various delivery or access modes (i.e., at diagnostic centres, SMS, email and web portal) for test reports. Several factors, including the strength of its brand, integrated services model, quality of its diagnostic services, center infrastructure and customer experience, convenience of its operational network and home collection in its core geographies are important differentiating factors in customers choosing it as their preferred diagnostic service provider, which helps it in retaining its customers, and sets it apart from its competitors.

Business area of the company

The company is one of the fastest-growing diagnostic chains in Southern India. It offers a one-stop solution for pathology and radiology testing services.

Awards, accreditations and recognitions

2012: The company was recognised as one of the Best Imaging Centres in Hyderabad the Week- Hansa Research national survey 2012.
2018: The company was awarded the Healthcare Leadership Award at the Telangana Healthcare Leadership Award 2018.
2018: The Company was awarded the Fastest Growing Brand (Pride of the Nation) 2018-2019 by United Research Services.
2018: The company’s centre at Gurgaon received the ISO 15189:2012 “Medical Laboratories - Requirements for quality and competence” for its facilities in the field of medical testing by NABL.
2019: The company was awarded the Best Diagnostic Centre of the Year, India - 2019 by the Times Healthcare Achievers, The Times of India.
2019: The company was awarded the Best Diagnostic Service Provider of the Year - 2019 at the Six Sigma Healthcare Excellence Awards, 2019.
2019: The company’s centre at Hanamkonda received the ISO 15189:2012 “Medical Laboratories - Requirements for quality and competence” for its facilities in the field of medical testing by NABL.
2019: The company’s centre at Kukatpally received scope of accreditation from NABH.
2020: The Company was awarded the Most Trusted and Best Quality Diagnostic Services in India - 2020 at the COVID Warriors Awards, 2020 by Topgallant Media.
2020: The company’s centre at Himayatnagar received the ISO 15189:2012 “Medical Laboratories - Requirements for quality and competence” for its facilities in the field of medical testing by NABL.
2020: The company’s centre at Sarojini Devi Road received scope of accreditation from NABH.
2020: The company’s centre at Habsiguda received the ISO 15189:2012 by NABL.
2021: The company has received the ‘Award of Excellence’ as the leading Imaging Centre (Multiple City) at the Radiology and Imaging Excellence Awards, 2021.
2021: The company was awarded the Award of Excellence for leading from the front during the pandemic under the Leading Diagnostic Chain of the Year by Elets Technomedia.
2021: The company received the certificate of recognition from the Economic Times as one of the Best Healthcare Brands -2021.

Major events and milestones

2005: Business was transferred from proprietorship to the company.
2008: First independent diagnostic centre in South India to get PET CT from Wipro GE Healthcare Private Limited.
2014: Acquisition of majority shareholding in 'Medinova Diagnostic Services Limited'.
2016: Investment by Karakoram Limited and Kedaara Capital Alternative Investment Fund - Kedaara Capital AIF 1.
2021: First independent diagnostic centre in the State of Telangana to get Revolution ACT 50 slice CT from Wipro GE Healthcare Private Limited.